BNET Industries

Last Fiscal Year Sales:$31.1M
  • Public
  • US
Dow Jones Description

Third Wave Technologies, Inc. is a leading molecular diagnostics company. We believe our proprietary Invader chemistry, a novel, molecular chemistry, is easier to use and more accurate than competing technologies. These and other advantages conferred by our chemistry enable us to provide clinicians and researchers with superior molecular solutions. More than 230 clinical laboratory customers are using Third Waves molecular diagnostic reagents. Other customers include pharmaceutical and biotechnology companies, academic research centers and major health care providers. Currently, one of our key strategic initiatives is the commercialization of our Human Papillomavirus (HPV) offering. In August 2006, we began clinical trials for two HPV pre-market approval submissions to the FDA. We expect to spend $18 million on these submissions over three years, however, this amount could vary pending FDA review and ongoing trial performance. In March 2008, we disclosed the achievement of positive clinical trial data, in which we achieved all primary clinical endpoints in the clinical trial for our human papillomavirus (HPV) tests. The Company submitted the pre-market approval application to the U.S. Food and Drug Administration for both its high-risk and 16/18 genotyping products in April 2008. If for any reason we are unable to successfully commercialize our HPV offering, our business and prospects would likely be materially adversely impacted. ...

President & CEO
Kevin Conroy
Number of Employees 179
Contact Information

502 S Rosa Rd

Madison, Wisconsin 53719-1256

www.twt.com

(608) 273-8933

NAICS Code Biological Product (except Diagnostic) Manufacturing: 325414

Recent Events

  • Badger State's tech boom

    10/01/09 - Merger / Acquisition - View Story

Decision Makers

Name (plus bio) Position
Kevin Conroy President & CEO
Chris Burton Senior Vice President Sales & Marketing
Ivan Trifunovich Senior Vice President
Jorge A. Garces Senior Vice President R&D
Gregory Hamilton Vice President, Finance and Operations
John Bellano Vice President, Sales
John Ballano
G. Burrill Director
Sam Eletr Director

Board of Directors

Name (plus bio) Position
Dan Broderick Board of Directors
David A. Thompson Board of Directors
Gorden F. Brunner Board of Directors
James J. Herrmann Board of Directors
Kay Napier Board of Directors

Organization Position Status
Third Wave Technologies, Inc. President & CEO Current
EXACT Sciences Corporation President and Chief Executive Officer Current
EXACT Sciences Corporation President, Chief Executive Former
Thirdwave, LLC President Former
Third Wave Technologies, Inc. Chief Executive Former
Thirdwave, LLC Chief Executive Former
EXACT Sciences Corporation Vice President Former
Thirdwave, LLC Vice President of Legal Affairs Former
McDermott Will & Emery intellectual property litigator Former
Pattishall Property Litigator Former
GE Healthcare Former
Michigan State University Bachelor's Degree In Electrical Engineering Former
University of Michigan Degree Former
EXACT Sciences Corporation Board of Directors Current

Organization Position Status
Third Wave Technologies, Inc. Senior Vice President Sales & Marketing Current

Ivan D. Trifunovich, Ph.D. (43) , joined us as Senior Vice President in December 2001. Dr. Trifunovich previously held successive positions as Vice President of e-Business and Vice President of Research Strategy and Operations at Pharmacia Corp. Prior to joining Pharmacia, Dr. Trifunovich was a Director of New Product Marketing at Johnson & Johnson, Inc. He began his career at Bristol-Meyers Squibb, Inc. as a bench scientist, where he held several positions of increasing responsibility. Dr. Trifunovich received his Ph.D. in organic chemistry at UCLA and an M.B.A. at the University of Pennsylvania s Wharton School of Business. He is the holder of 10 U.S. patents.

Organization Position Status
Third Wave Technologies, Inc. Senior Vice President Current
Crosslink Genetics Corp. A. Senior Vice President and General Manager, Third Wave Technologies Current
Pharmacia Corporation Vice President of Research Strategy and Operations Former
Johnson & Johnson Director of New Product Marketing Former
Bristol-Myers Squibb Company Scientist Former
University of California, Los Angeles Ph.D. In Chemistry Former

Organization Position Status
Third Wave Technologies, Inc. Senior Vice President R&D Current
Thirdwave, LLC Executive Director of Clinical Development Current
Third Wave Technologies, Inc. Vice President, Research and Development Former
Genzyme Corporation Vice President, Research and Development Former
Genzyme Corporation Executive Director Former
Genzyme Genetics Director of Molecular Research and Development Former
Athena Diagnostics, Inc. Associate Product Manager Former
Athena Diagnostics, Inc. Research and Development Scientist Former
Proteome, Inc. Scientist Former
Genzyme Corporation Director Former
City University of New York Doctorate In Cell Former
Brooklyn College Bachelor's Degree In Biology Former
University of Massachusetts Medical School Postdoctoral Former

Organization Position Status
Third Wave Technologies, Inc. Vice President, Finance and Operations Current
Thirdwave, LLC Executive Director Current
Planning Ltd. Executive Director Current

Organization Position Status
Thirdwave, LLC Regional Vice President of Sales Current
Third Wave Technologies, Inc. Vice President, Sales Current

Organization Position Status
Third Wave Technologies, Inc. Current
Roche Diagnostics Corporation Former
Abbott Laboratories Former

Organization Position Status
Deltanoid Pharmaceuticals Inc Managing Director Current
Prolog Ventures Managing Director Current
Venture Investors LLC Co-Founder Current
Pro-Log Venture Partner Current
Zystor Therapeutics, Inc Mason Current
Tandem Press Current
University of Wisconsin Current
Prolog Ventures Board of Directors Current
Zystor Therapeutics, Inc Board of Directors Current
Asoyia Board of Directors Current
CS-Keys, Inc. Board of Directors Current
TomoTherapy Incorporated Board of Directors Current
Third Wave Technologies, Inc. Board of Directors Current
Deltanoid Pharmaceuticals Inc Board of Directors Current
Eragen Biosciences, Inc. Board of Directors Current
Mason Wells Managing Director Former
Prolog Ventures Partner Former
Mayo Clinic Director of the Office of Technology Commercialization Former
Mayo Clinic Appointment to the Staff Former
Deltanoid Pharmaceuticals Inc Mason Former
Mezzia, Inc. Director Former
The Wisconsin Technology Council Board of Directors Former
Gala Design Director Former
University of Wisconsin-Madison Ms In Marketing and Finance Former
University of Utah Bs In Finance Former
Iowa State University Bachelors Degree Former
Mason Wells Member Former

Organization Position Status
Abbott Diagnostics President Current
Hycor Biomedical, Inc. Board of Directors Current
LifeCell Corporation Board of Directors Current
NABI Board of Directors Current
Third Wave Technologies, Inc. Board of Directors Current
Third Wave Technologies, Inc. Chairman & President Former
Abbott Laboratories Vice President Former
Abbott Laboratories Corporate Officer Former
St. Jude Medical, Inc. Board of Directors Former

G. Steven Burrill has been involved in the growth and prosperity of the biotechnology industry for over 40 years. An early pioneer, Mr. Burrill is one of the original architects of the industry and one of its most avid and sustained developers. He currently serves as Chairman of the Board of Pharmasset (NASDAQ: VRUS) and is a member of the Boards of Directors of Catalyst Biosciences, DepoMed (NASDAQ: DEPO), Intranasal, Phytomedics, Proteogenix, Proventys, Targacept (NASDAQ: TRGT) and XDx. Prior to founding Burrill & Company in 1994, he spent 28 years with Ernst & Young, directing and coordinating the firm's services to clients in the biotechnology/life sciences/high technology/manufacturing industries worldwide. In 2002, Mr. Burrill was recognized as the biotech investment visionary by the prestigious Scientific American magazine (The Scientific American 50). Mr. Burrill is a founder and currently serves as the Chairman of the Board of the Foundation for the National Medals of Science and Technology. Additionally, he serves as Chairman of the Board on Campaign for Medical Research as well as Chairman of the San Francisco Mayor?s Biotech Advisory Committee (MAYBAC). Other not-for-profit activities include serving on the Boards of Directors for the Bay Area Science Infrastructure Consortium, BayBio, California Healthcare Institute, The Exploratorium, Genetics Policy Institute, The Kellogg Center for Biotechnology, Kramden Institute, The National Health Museum, and Research!America. He also serves as an advisor on the MIT Center for Biomedical Innovation.

Organization Position Status
Burrill & Company CEO Current
National Medals President, Chairman of the Board Current
National Medals Founder Current
University of California adjunct professor Current
University of California, San Francisco Adjunct Professor Current
Pjb Publications, Ltd. Current
Pyxis Genomics, Inc. Chairman of the Boards Current
Pharmasset, Inc. Chairman of the Boards Current
Icoria Inc. Chairman of the Boards Current
Andrx Corporation Chairman Current
Bioimagene, Inc. Chairman Current
Newbridge Chairman of The Boards Current
Proventys, Inc. Board of Directors Current
BayBio Director Current
Bioexec Ventures, LLC Board of Directors Current
Crosscart, Inc Board of Directors Current
Pharmasset, Inc. Board of Directors Current
Clinical Data Inc. Board of Directors Current
Intranasal Technology, Inc Board of Directors Current
Kramden Institute Board Member Current
Depomed, Inc. Board of Directors Current
Third Wave Technologies, Inc. Director Current
University of California Director Current
California Healthcare Institute, Inc. Board of Directors Current
The National Health Museum, Inc Treasurer Current
Catalyst Biosciences, Inc. Board of Directors Current
Proteogenix, Inc. Board of Directors Current
The Center for Policy On Emerging Technologies, Inc. Board of Directors Current
Phytomedics, Inc. Board of Directors Current
Depomed, Inc. Chief Executive Officer, Burrill & Company Former
Burrill & Company Founder Current
The Center for Policy On Emerging Technologies, Inc. CEO, Burrill and Company, San Francisco Former
Pharmasset, Inc. President and CEO of Pharmasset, Inc. Former
Craves Founder Former
Icoria Inc. Board of Directors Former
Ernst & Young Director Former

Organization Position Status
Third Wave Technologies, Inc. Board of Directors Current

Organization Position Status
Tolera Systems LLC Chief Operating Officer Current
Third Wave Technologies, Inc. Board of Directors Current
Third Wave Technologies, Inc. Vice President, Finance Former
University of Chicago Former

Organization Position Status
Third Wave Technologies, Inc. Board of Directors Current

Organization Position Status
Red Abbey, LLC Senior Advisor Current
Spinx Technologies Chairman of the Board Current
Faust Pharmaceuticals Sa Board of Directors Current
Third Wave Technologies, Inc. Director Current
Applied Biosystems Group Co-Founder Former
Hewlett-Packard Company Manager Former
I-Stat Corp Board Director Former
Solexa, Inc. Director Former
University of California Ph.D Former
University of California, Berkeley PhD In Biophysical Chemistry Former
University of California, Berkeley M.A. In Physics Former
University of California MA Former

Executive News

  • Biotech Cools Off in August But Capital Markets Remain Positive

    NewsBlaze - 9/01/09 - View Story

  • Exact Sciences reports second quarter loss

    Milwaukee Journal Sentinel - 8/12/09 - View Story

  • Exact Sciences Reports Second-Quarter 2009 Financial Results

    Business Wire - 8/12/09 - View Story

advertisement
advertisement